Loading...
Treatment of Bone Fragility in Patients with Diabetes: Antiresorptive versus Anabolic?
PURPOSE OF REVIEW: The pathogenesis of bone fragility in diabetes has not been fully characterized. The anti-fracture efficacy of available therapies remains unproven in patients with diabetes. We aim to collate current evidence of the treatment of diabetic bone fragility, and to provide a rationale...
Saved in:
| Published in: | Curr Opin Endocrinol Diabetes Obes |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8244995/ https://ncbi.nlm.nih.gov/pubmed/34010225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0000000000000645 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|